Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 84.36M | $1.14B | 7.30% | -2.47M | 2026-03-31 |
| Davis Selected Advisers | 78.21M | $1.06B | 6.77% | +33.2K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 74.72M | $1.01B | 6.47% | -- | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 65.86M | $889.0M | 5.70% | -13.22M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 53.91M | $728.0M | 4.67% | -- | 2026-03-31 |
| STATE STREET CORP | 52.23M | $705.0M | 4.52% | -3.08M | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 38.31M | $517.0M | 3.32% | -1.72M | 2026-03-31 |
| Rubric Capital Management LP | 33.50M | $452.0M | 2.90% | +8.00M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 31.85M | $429.0M | 2.76% | +739.2K | 2026-03-31 |
| Invesco Ltd. | 21.97M | $296.0M | 1.90% | -1.36M | 2026-03-31 |
